Role of divalent metals in infectious disease susceptibility and outcome

Clinical Microbiology and Infection

Volumn 24, Issue 1, 2018, Pages 16-23

  Weiss, G ^a   Carver, P L ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Copper; HIV; Immunity; Iron; Malaria; Manganese; Microbe; Selenium; Sepsis; Zinc

Indexed keywords

COPPER; IRON; MANGANESE; METAL; SELENIUM; ZINC; ANTIOXIDANT; DIVALENT CATION;

DISEASE PREDISPOSITION; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION; MEDLINE; MICROORGANISM; NONHUMAN; NUTRITIONAL IMMUNITY; OUTCOME ASSESSMENT; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; BACTERIAL INFECTION; BACTERIUM; FUNGUS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MYCOSIS;

ANTIOXIDANTS; BACTERIA; BACTERIAL INFECTIONS; CATIONS, DIVALENT; COPPER; DISEASE SUSCEPTIBILITY; FUNGI; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IRON; MANGANESE; MYCOSES; SELENIUM; ZINC;

EID: 85014281413     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2017.01.018     Document Type: Review

References (139)

1. Balamtekin, N., Kurekci, A.E., Atay, A., Kalman, S., Okutan, V., Gokcay, E., et al. Plasma levels of trace elements have an implication on interferon treatment of children with chronic hepatitis B infection. Biol Trace Elem Res 135 (2010), 153–161.
2. Kassu, A., Yabutani, T., Mahmud, Z.H., Mohammad, A., Nguyen, N., Huong, B.T., et al. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur J Clin Nutr 60 (2006), 580–586.
3. Klein, J.S., Lewinson, O., Bacterial ATP-driven transporters of transition metals: physiological roles, mechanisms of action, and roles in bacterial virulence. Metallomics 3 (2011), 1098–1108.
4. Carver, P.L., Metal ions and infectious diseases. An overview from the clinic. Met Ions Life Sci 13 (2013), 1–28.
5. German, N., Luthje, F., Hao, X., Ronn, R., Rensing, C., Microbial virulence and interactions with metals. Progr Mol Biol Transl Sci 142 (2016), 27–49.
6. Cassat, J.E., Skaar, E.P., Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol 34 (2012), 215–235.
7. Skaar, E.P., Raffatellu, M., Metals in infectious diseases and nutritional immunity. Metallomics 7 (2015), 926–928.
8. Damo, S.M., Kehl-Fie, T.E., Sugitani, N., Holt, M.E., Rathi, S., Murphy, W.J., et al. Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc Natl Acad Sci U S A 110 (2013), 3841–3846.
9. Diaz-Ochoa, V.E., Jellbauer, S., Klaus, S., Raffatellu, M., Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol, 4, 2014, 2.
10. Jerome, O., Nriagu, E.P.S., Trace metals and infectious diseases. 2015, MIT Press, Cambridge, MA.
11. Weinberg, E.D., Nutritional immunity. Host's attempt to withold iron from microbial invaders. JAMA 231 (1975), 39–41.
12. Hood, M.I., Skaar, E.P., Nutritional immunity: transition metals at the pathogen–host interface. Nat Rev Microbiol 10 (2012), 525–537.
13. Manzanares, W., Dhaliwal, R., Jiang, X., Murch, L., Heyland, D.K., Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care, 16, 2012, R66.
14. Btaiche, I.F., Carver, P.L., Welch, K.B., Dosing and monitoring of trace elements in long-term home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 35 (2011), 736–747.
15. Berger, M.M., Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 21 (2006), 438–449.
16. Geoghegan, M., McAuley, D., Eaton, S., Powell-Tuck, J., Selenium in critical illness. Curr Opin Crit Care 12 (2006), 136–141.
17. Subramanian Vignesh, K., Deepe, G.S. Jr., Immunological orchestration of zinc homeostasis: the battle between host mechanisms and pathogen defenses. Arch Biochem Biophys 611 (2016), 66–78.
18. Völlger, L., Akong-Moore, K., Cox, L., Goldmann, O., Wang, Y., Schäfer, S.T., et al. Iron-chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood–derived neutrophils. Biosci Rep, 36, 2016, e00333.
19. Zackular, J.P., Chazin, W.J., Skaar, E.P., Nutritional immunity: S100 proteins at the host–pathogen interface. J Biol Chem 290 (2015), 18991–18998.
20. Barber, M.F., Elde, N.C., Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science 346 (2014), 1362–1366.
21. Szebesczyk, A., Olshvang, E., Shanzer, A., Carver, P.L., Gumienna-Kontecka, E., Harnessing the power of fungal siderophores for the imaging and treatment of human diseases. Coordination Chem Rev 327–328 (2016), 84–109.
22. Palmer, L.D., Skaar, E.P., Transition metals and virulence in bacteria. Annu Rev Genet 50 (2016), 67–91.
23. Juttukonda, L.J., Chazin, W.J., Skaar, E.P., Acinetobacter baumannii coordinates urea metabolism with metal import to resist host-mediated metal limitation. mBio, 7, 2016.
24. Mathew, A., Jenul, C., Carlier, A.L., Eberl, L., The role of siderophores in metal homeostasis of members of the genus Burkholderia. Environ Microbiol Rep 8 (2016), 103–109.
25. Schalk, I.J., Hannauer, M., Braud, A., New roles for bacterial siderophores in metal transport and tolerance. Environ Microbiol 13 (2011), 2844–2854.
26. Braud, A., Geoffroy, V., Hoegy, F., Mislin, G.L., Schalk, I.J., Presence of the siderophores pyoverdine and pyochelin in the extracellular medium reduces toxic metal accumulation in Pseudomonas aeruginosa and increases bacterial metal tolerance. Environ Microbiol Rep 2 (2010), 419–425.
27. Chaturvedi, K.S., Henderson, J.P., Pathogenic adaptations to host-derived antibacterial copper. Front Cell Infect Microbiol, 4, 2014, 3.
28. Kohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., et al. In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob Agents Chemother 60 (2016), 729–734.
29. Page, M.G., Siderophore conjugates. Ann N Y Acad Sci 1277 (2013), 115–126.
30. Ghssein, G., Brutesco, C., Ouerdane, L., Fojcik, C., Izaute, A., Wang, S., et al. Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus. Science 352 (2016), 1105–1109.
31. Gi, M., Lee, K.M., Kim, S.C., Yoon, J.H., Yoon, S.S., Choi, J.Y., A novel siderophore system is essential for the growth of Pseudomonas aeruginosa in airway mucus. Sci Rep, 5, 2015, 14644.
32. Weiss, G., Goodnough, L.T., Anemia of chronic disease. N Engl J Med 352 (2005), 1011–1023.
33. Soares, M.P., Weiss, G., The iron age of host–microbe interactions. EMBO Rep 16 (2015), 1482–1500.
34. Ganz, T., Nemeth, E., Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15 (2015), 500–510.
35. Nairz, M., Haschka, D., Demetz, E., Weiss, G., Iron at the interface of immunity and infection. Front Pharmacol, 5, 2014, 152.
36. Drakesmith, H., Prentice, A.M., Hepcidin and the iron–infection axis. Science 338 (2012), 768–772.
37. Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., et al. Nitric oxide–mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med 210 (2013), 855–873.
38. Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114 (2009), 3642–3651.
39. Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P.A., et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17 (2015), 47–57.
40. Nairz, M., Ferring-Appel, D., Casarrubea, D., Sonnweber, T., Viatte, L., Schroll, A., et al. Iron regulatory proteins mediate host resistance to Salmonella infection. Cell Host Microbe 18 (2015), 254–261.
41. Portugal, S., Carret, C., Recker, M., Armitage, A.E., Gonçalves, L.A., Epiphanio, S., et al. Host-mediated regulation of superinfection in malaria. Nat Med 17 (2011), 732–737.
42. Nakashige, T.G., Zhang, B., Krebs, C., Nolan, E.M., Human calprotectin is an iron-sequestering host-defense protein. Nat Chem Biol 11 (2015), 765–771.
43. Cellier, M.F., Nutritional immunity: homology modeling of Nramp metal import. Adv Exp Med Biol 946 (2012), 335–351.
44. Weiss, G., Schaible, U.E., Macrophage defense mechanisms against intracellular bacteria. Immunol Rev 264 (2015), 182–203.
45. Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rogers, T., Arst, H.N. Jr., et al. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med 200 (2004), 1213–1219.
46. Crouch, M.L., Castor, M., Karlinsey, J.E., Kalhorn, T., Fang, F.C., Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol 67 (2008), 971–983.
47. Deriu, E., Liu, J.Z., Pezeshki, M., Edwards, R.A., Ochoa, R.J., Contreras, H., et al. Probiotic bacteria reduce Salmonella Typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14 (2013), 26–37.
48. Lokken, K.L., Tsolis, R.M., Baumler, A.J., Hypoferremia of infection: a double-edged sword?. Nat Med 20 (2014), 335–337.
49. Kim, D.K., Jeong, J.H., Lee, J.M., Kim, K.S., Park, S.H., Kim, Y.D., et al. Inverse agonist of estrogen-related receptor gamma controls Salmonella Typhimurium infection by modulating host iron homeostasis. Nat Med 20 (2014), 419–424.
50. Gwamaka, M., Kurtis, J.D., Sorensen, B.E., Holte, S., Morrison, R., Mutabingwa, T.K., et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin Infect Dis 54 (2012), 1137–1144.
51. Kabyemela, E.R., Fried, M., Kurtis, J.D., Mutabingwa, T.K., Duffy, P.E., Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J Infect Dis 198 (2008), 163–166.
52. Soofi, S., Cousens, S., Iqbal, S.P., Akhund, T., Khan, J., Ahmed, I., et al. Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial. Lancet 382 (2013), 29–40.
53. Sazawal, S., Black, R.E., Ramsan, M., Chwaya, H.M., Stoltzfus, R.J., Dutta, A., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367 (2006), 133–143.
54. Zlotkin, S., Newton, S., Aimone, A.M., Azindow, I., Amenga-Etego, S., Tchum, K., et al. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA 310 (2013), 938–947.
55. Weinberg, E.D., Iron availability and infection. Biochim Biophys Acta 1790 (2009), 600–605.
56. Alessandrino, E.P., Della Porta, M.G., Bacigalupo, A., Malcovati, L., Angelucci, E., Van Lint, M.T., et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95 (2010), 476–484.
57. Hershko, C., Peto, T.E., Weatherall, D.J., Iron and infection. Br Med J (Clin Res Ed) 296 (1988), 660–664.
58. Kontoyiannis, D.P., Chamilos, G., Lewis, R.E., Giralt, S., Cortes, J., Raad, I.I., et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110 (2007), 1303–1306.
59. Binder, U., Maurer, E., Lass-Florl, C., Mucormycosis—from the pathogens to the disease. Clin Microbiol Infect 20:Suppl. 6 (2014), 60–66.
60. Spellberg, B., Ibrahim, A.S., Chin-Hong, P.V., Kontoyiannis, D.P., Morris, M.I., Perfect, J.R., et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 67 (2012), 715–722.
61. Macdougall, I.C., Bircher, A.J., Eckardt, K.U., Obrador, G.T., Pollock, C.A., Stenvinkel, P., et al. Iron management in chronic kidney disease: conclusions from a ‘Kidney Disease: Improving Global Outcomes’ (KDIGO) controversies conference. Kidney Int 89 (2016), 28–39.
62. Ghio, A.J., Particle exposures and infections. Infection 42 (2014), 459–467.
63. Isanaka, S., Aboud, S., Mugusi, F., Bosch, R.J., Willett, W.C., Spiegelman, D., et al. Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS One, 7, 2012, e37350.
64. McDermid, J.M., Hennig, B.J., van der Sande, M., Hill, A.V., Whittle, H.C., Jaye, A., et al. Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis, 13, 2013, 48.
65. Porter, K.M., Sutliff, R.L., HIV-1, reactive oxygen species, and vascular complications. Free Radic Biol Med 53 (2012), 143–159.
66. Hurwitz, B.E., Klaus, J.R., Llabre, M.M., Gonzalez, A., Lawrence, P.J., Maher, K.J., et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med 167 (2007), 148–154.
67. Stone, C.A., Kawai, K., Kupka, R., Fawzi, W.W., Role of selenium in HIV infection. Nutr Rev 68 (2010), 671–681.
68. Look, M.P., Rockstroh, J.K., Rao, G.S., Kreuzer, K.A., Spengler, U., Sauerbruch, T., Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 56 (1997), 31–41.
69. Campa, A., Shor-Posner, G., Indacochea, F., Zhang, G., Lai, H., Asthana, D., et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 20 (1999), 508–513.
70. Baum, M.K., Shor-Posner, G., Lai, S., Zhang, G., Lai, H., Fletcher, M.A., et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 15 (1997), 370–374.
71. Kupka, R., Msamanga, G.I., Spiegelman, D., Morris, S., Mugusi, F., Hunter, D.J., et al. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 134 (2004), 2556–2560.
72. Cirelli, A., Ciardi, M., de Simone, C., Sorice, F., Giordano, R., Ciaralli, L., et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 24 (1991), 211–214.
73. Shor-Posner, G., Lecusay, R., Miguez, M.J., Moreno-Black, G., Zhang, G., Rodriguez, N., et al. Psychological burden in the era of HAART: impact of selenium therapy. Int J Psychiatry Med 33 (2003), 55–69.
74. Kupka, R., Msamanga, G.I., Spiegelman, D., Rifai, N., Hunter, D.J., Fawzi, W.W., Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr 59 (2005), 1250–1258.
75. Shivakoti, R., Gupte, N., Yang, W.T., Mwelase, N., Kanyama, C., Tang, A.M., et al. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy. Nutrients 6 (2014), 5061–5078.
76. Drain, P.K., Baeten, J.M., Overbaugh, J., Wener, M.H., Bankson, D.D., Lavreys, L., et al. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis, 6, 2006, 85.
77. Baum, M.K., Campa, A., Lai, S., Sales Martinez, S., Tsalaile, L., Burns, P., et al. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. JAMA 310 (2013), 2154–2163.
78. Burbano, X., Miguez-Burbano, M.J., McCollister, K., Zhang, G., Rodriguez, A., Ruiz, P., et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials 3 (2002), 483–491.
79. Kupka, R., Mugusi, F., Aboud, S., Msamanga, G.I., Finkelstein, J.L., Spiegelman, D., et al. Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes. Am J Clin Nutr 87 (2008), 1802–1808.
80. + T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial. AIDS 29 (2015), 1045–1052.
81. Jones, C.Y., Tang, A.M., Forrester, J.E., Huang, J., Hendricks, K.M., Knox, T.A., et al. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the nutrition for healthy living cohort. J Acquir Immune Defic Syndr 43 (2006), 475–482.
82. McClelland, R.S., Baeten, J.M., Overbaugh, J., Richardson, B.A., Mandaliya, K., Emery, S., et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial. J Acquir Immune Defic Syndr 37 (2004), 1657–1663.
83. Kelly, P., Musonda, R., Kafwembe, E., Kaetano, L., Keane, E., Farthing, M., Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: a randomized controlled trial. AIDS 13 (1999), 495–500.
84. Fawzi, W.W., Msamanga, G.I., Spiegelman, D., Wei, R., Kapiga, S., Villamor, E., et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 351 (2004), 23–32.
85. Kaiser, J.D., Campa, A.M., Ondercin, J.P., Leoung, G.S., Pless, R.F., Baum, M.K., Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr 42 (2006), 523–528.
86. Durosinmi, M.A., Armistead, H., Akinola, N.O., Onayemi, O., Adediran, I.A., Olasode, O.A., et al. Selenium and aspirin in people living with HIV and AIDS in Nigeria. Niger Postgrad Med J 15 (2008), 215–218.
87. Irlam, J.H., Visser, M.M., Rollins, N.N., Siegfried, N., Micronutrient supplementation in children and adults with HIV. infection. Cochrane Database Syst Rev(12), 2010, CD003650.
88. Siegfried, N., Irlam, J.H., Visser, M.E., Rollins, N.N., Micronutrient supplementation in pregnant women with HIV infection. Cochrane Database Syst Rev(3), 2012, CD009755.
89. Grobler, L., Nagpal, S., Sudarsanam, T.D., Sinclair, D., Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev(6), 2016, CD006086.
90. Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P., Chappuis, P., Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 26 (1998), 1536–1544.
91. Sakr, Y., Reinhart, K., Bloos, F., Marx, G., Russwurm, S., Bauer, M., et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 98 (2007), 775–784.
92. Forceville, X., Laviolle, B., Annane, D., Vitoux, D., Bleichner, G., Korach, J.M., et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care, 11, 2007, R73.
93. Andrews, P.J., Avenell, A., Noble, D.W., Campbell, M.K., Croal, B.L., Simpson, W.G., et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ, 342, 2011, d1542.
94. Darlow, B.A., Austin, N.C., Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev(4), 2003, CD003312.
95. Carcillo, J.A., Dean, J.M., Holubkov, R., Berger, J., Meert, K.L., Anand, K.J., et al. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med 13 (2012), 165–173.
96. Manzanares, W., Lemieux, M., Elke, G., Langlois, P.L., Bloos, F., Heyland, D.K., High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis. Crit Care, 20, 2016, 356.
97. Allingstrup, M., Afshari, A., Selenium supplementation for critically ill adults. Cochrane Database Syst Rev(7), 2015, CD003703.
98. Landucci, F., Mancinelli, P., De Gaudio, A.R., Virgili, G., Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J Crit Care 29 (2014), 150–156.
99. Huang, T.S., Shyu, Y.C., Chen, H.Y., Lin, L.M., Lo, C.Y., Yuan, S.S., et al. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One, 8, 2013, e54431.
100. Alhazzani, W., Jacobi, J., Sindi, A., Hartog, C., Reinhart, K., Kokkoris, S., et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 41 (2013), 1555–1564.
101. Heyland, D.K., Dhaliwal, R., Suchner, U., Berger, M.M., Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31 (2005), 327–337.
102. Kong, Z., Wang, F., Ji, S., Deng, X., Xia, Z., Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials. Am J Emerg Med 31 (2013), 1170–1175.
103. Bloos, F., Trips, E., Nierhaus, A., Briegel, J., Heyland, D.K., Jaschinski, U., et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med 176 (2016), 1266–1276.
104. Heyland, D., Muscedere, J., Wischmeyer, P.E., Cook, D., Jones, G., Albert, M., et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368 (2013), 1489–1497.
105. Chelkeba, L., Ahmadi, A., Abdollahi, M., Najafi, A., Ghadimi, M.H., Mosaed, R., et al. The effect of parenteral selenium on outcomes of mechanically ventilated patients following sepsis: a prospective randomized clinical trial. Ann Intensive Care, 5, 2015, 29.
106. Woth, G., Nagy, B., Mérei, Á., Ernyey, B., Vincze, R., Kaurics, Z., et al. The effect of Na-selenite treatment on the oxidative stress–antioxidants balance of multiple organ failure. J Crit Care., 29(5), 2014 Oct 883.e7–11.
107. Baum, M.K., Lai, S., Sales, S., Page, J.B., Campa, A., Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis 50 (2010), 1653–1660.
108. Kehl-Fie, T.E., Skaar, E.P., Nutritional immunity beyond iron: a role for manganese and zinc. Curr Opin Chem Biol 14 (2010), 218–224.
109. Prasad, A.S., Beck, F.W., Bao, B., Fitzgerald, J.T., Snell, D.C., Steinberg, J.D., et al. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85 (2007), 837–844.
110. Laskaris, P., Atrouni, A., Calera, J.A., d'Enfert, C., Munier-Lehmann, H., Cavaillon, J.M., et al. Administration of zinc chelators improves survival of mice infected with Aspergillus fumigatus both in monotherapy and in combination with caspofungin. Antimicrob Agents Chemother 60 (2016), 5631–5639.
111. Livingstone, C., Zinc: physiology, deficiency, and parenteral nutrition. Nutr Clin Pract 30 (2015), 371–382.
112. Basnet, S., Mathisen, M., Strand, T.A., Oral zinc and common childhood infections—an update. J Trace Elem Med Biol 31 (2015), 163–166.
113. Yakoob, M.Y., Theodoratou, E., Jabeen, A., Imdad, A., Eisele, T.P., Ferguson, J., et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health, 11(Suppl. 3), 2011, S23.
114. Bhutta, Z.A., Bird, S.M., Black, R.E., Brown, K.H., Gardner, J.M., Hidayat, A., et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 72 (2000), 1516–1522.
115. Aggarwal, R., Sentz, J., Miller, M.A., Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 119 (2007), 1120–1130.
116. Martinez-Estevez, N.S., Alvarez-Guevara, A.N., Rodriguez-Martinez, C.E., Effects of zinc supplementation in the prevention of respiratory tract infections and diarrheal disease in Colombian children: a 12-month randomised controlled trial. Allergol Immunopathol (Madr) 44 (2016), 368–375.
117. McDonald, C.M., Manji, K.P., Kisenge, R., Aboud, S., Spiegelman, D., Fawzi, W.W., et al. Daily zinc but not multivitamin supplementation reduces diarrhea and upper respiratory infections in Tanzanian infants: a randomized, double-blind, placebo-controlled clinical trial. J Nutr 145 (2015), 2153–2160.
118. Mayo-Wilson, E., Junior, J.A., Imdad, A., Dean, S., Chan, X.H., Chan, E.S., et al. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev(5), 2014, CD009384.
119. Gulani, A., Sachdev, H.S., Zinc supplements for preventing otitis media. Cochrane Database Syst Rev(6), 2014, CD006639.
120. Somé J.W., Abbeddou, S., Yakes Jimenez, E., Hess, S.Y., Ouédraogo, Z.P., Guissou, R.M., et al. Effect of zinc added to a daily small-quantity lipid-based nutrient supplement on diarrhoea, malaria, fever and respiratory infections in young children in rural Burkina Faso: a cluster-randomised trial. BMJ Open, 5, 2015, e007828.
121. Tie, H.T., Tan, Q., Luo, M.Z., Li, Q., Yu, J.L., Wu, Q.C., Zinc as an adjunct to antibiotics for the treatment of severe pneumonia in children <5 years: a meta-analysis of randomised-controlled trials. Br J Nutr 115 (2016), 807–816.
122. Van Biervliet, S., Van Biervliet, J.P., Vande Velde, S., Robberecht, E., Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation. Biol Trace Elem Res 119 (2007), 19–26.
123. Abdulhamid, I., Beck, F.W., Millard, S., Chen, X., Prasad, A., Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol 43 (2008), 281–287.
124. Van Biervliet, S., Vande Velde, S., Van Biervliet, J.P., Robberecht, E., The effect of zinc supplements in cystic fibrosis patients. Ann Nutr Metab 52 (2008), 152–156.
125. Sharma, G., Lodha, R., Shastri, S., Saini, S., Kapil, A., Singla, M., et al. Zinc supplementation for one year among children with cystic fibrosis does not decrease pulmonary infection. Respir Care 61 (2016), 78–84.
126. Heyland, D.K., Jones, N., Cvijanovich, N.Z., Wong, H., Zinc supplementation in critically ill patients: a key pharmaconutrient?. JPEN J Parenter Enteral Nutr 32 (2008), 509–519.
127. Zackular, J.P., Moore, J.L., Jordan, A.T., Juttukonda, L.J., Noto, M.J., Nicholson, M.R., et al. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat Med 2016;22:1330–4. Erratum. Nat Med, 22, 2016, 1502.
128. Seekatz, A.M., Young, V.B., Infection: modulation of Clostridium difficile infection by dietary zinc. Nat Rev Gastroenterol Hepatol 13 (2016), 686–688.
129. Singh, M., Das, R.R., Zinc for the common cold. Cochrane Database Syst Rev(2), 2011, CD001364.
130. Solioz, M., The copper rush of the nineties. Metallomics 8 (2016), 824–830.
131. Pantopoulos, K., Porwal, S.K., Tartakoff, A., Devireddy, L., Mechanisms of mammalian iron homeostasis. Biochemistry 51 (2012), 5705–5724.
132. Samanovic, M.I., Ding, C., Thiele, D.J., Darwin, K.H., Copper in microbial pathogenesis: meddling with the metal. Cell Host Microbe 11 (2012), 106–115.
133. Besold, A.N., Culbertson, E.M., Culotta, V.C., The yin and yang of copper during infection. J Biol Inorg Chem 21 (2016), 137–144.
134. White, C., Lee, J., Kambe, T., Fritsche, K., Petris, M.J., A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem 284 (2009), 33949–33956.
135. Djoko, K.Y., Ong, C.L., Walker, M.J., McEwan, A.G., The role of copper and zinc toxicity in innate immune defense against bacterial pathogens. J Biol Chem 290 (2015), 18954–18961.
136. Potrykus, J., Ballou, E.R., Childers, D.S., Brown, A.J., Conflicting interests in the pathogen–host tug of war: fungal micronutrient scavenging versus mammalian nutritional immunity. PLoS Pathog, 10, 2014, e1003910.
137. Koltas, I.S., Ozcan, K., Tamer, L., Aksungur, P., Serum copper, zinc and magnesium levels in children with enterobiosis. J Trace Elem Med Biol 11 (1997), 49–52.
138. Humann-Ziehank, E., Menzel, A., Roehrig, P., Schwert, B., Ganter, M., Hennig-Pauka, I., Acute and subacute response of iron, zinc, copper and selenium in pigs experimentally infected with Actinobacillus pleuropneumoniae. Metallomics 6 (2014), 1869–1879.
139. Kehl-Fie, T.E., Zhang, Y., Moore, J.L., Farrand, A.J., Hood, M.I., Rathi, S., et al. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun 81 (2013), 3395–3405.